Multidrug-Resistant Infections
Pfizer’s Phase III Trials Bring Hope for Multidrug-Resistant Infections with Limited Treatment Options
SG Tylor
On June 1, 2023, Pfizer announced encouraging outcomes from its Phase III program that involved the REVISIT and ASSEMBLE trials. ...
